CCND1 and endometrioid adenocarcinoma: Atram et al. further distinguished Cyclin D1 expression by Type I and Type II endometrial cancer classifications, reporting that Cyclin D1 expression was predominantly associated with Type I tumors, corresponding to endometrioid adenocarcinomas, particularly those with poor differentiation.